A new integrated technology-driven screening approach will enable women to get tested for cervical cancer in the comfort of their own homes – a pioneering effort to detect cervical cancer in its early stages.
ROSE (Removing Obstacles to Cervical Screening), the world’s first cervical screening programme featuring self-sampling by women themselves, is a human papilloma virus (HPV) DNA test – rather than a Pap smear diagnostic test that uses microscopy – and is based on an e-health platform.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
